Search details
1.
Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews).
Lancet Oncol
; 23(10): e459-e468, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36174632
2.
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Lancet Oncol
; 22(10): 1367-1377, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34560006
3.
IARC Perspective on Oral Cancer Prevention.
N Engl J Med
; 387(21): 1999-2005, 2022 11 24.
Article
in English
| MEDLINE | ID: mdl-36378601
4.
Common Sense Oncology: outcomes that matter.
Lancet Oncol
; 24(8): 833-835, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37467768
5.
Global Landscape of the Attack of Predatory Journals in Oncology.
JCO Glob Oncol
; 10: e2300287, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38781549
6.
Perspective on oral cancer screening: Time for implementation research and beyond.
J Cancer Policy
; 35: 100381, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36599217
7.
Effectiveness of screening for oral cancer and oral potentially malignant disorders (OPMD): A systematic review.
Prev Med Rep
; 30: 101987, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36189128
8.
Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments.
Curr Oncol
; 29(8): 5774-5791, 2022 08 16.
Article
in English
| MEDLINE | ID: mdl-36005193
9.
Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.
JCO Glob Oncol
; 8: e2200034, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35749676
10.
Cancer Medicines: What Is Essential and Affordable in India?
JCO Glob Oncol
; 8: e2200060, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35853192
11.
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.
JCO Glob Oncol
; 7: 311-323, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33617304
12.
Impact of Strategies for Mitigating Delays and Disruptions in Cancer Care Due to COVID-19: Systematic Review.
JCO Glob Oncol
; 7: 342-352, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33656910
13.
Tracking the Workforce 2020-2030: Making the Case for a Cancer Workforce Registry.
JCO Glob Oncol
; 7: 925-933, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34138643
14.
Thyroid collision tumor containing oncocytic carcinoma, classical and hobnail variants of papillary carcinoma and areas of poorly differentiated carcinoma.
Arch Endocrinol Metab
; 65(4): 495-499, 2021 Nov 03.
Article
in English
| MEDLINE | ID: mdl-34283905
15.
Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer.
J Bras Pneumol
; 47(3): e20200378, 2021.
Article
in English, Portuguese
| MEDLINE | ID: mdl-33656100
16.
Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System.
J Bras Pneumol
; 46(4): e20180255, 2020.
Article
in Portuguese, English
| MEDLINE | ID: mdl-32490907
17.
In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments.
Value Health Reg Issues
; 20: 47-50, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-30856543
18.
Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study.
Sao Paulo Med J
; 137(6): 505-511, 2019.
Article
in English
| MEDLINE | ID: mdl-32159636
19.
Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer.
Arch Endocrinol Metab
; 62(3): 370-375, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29791660
20.
Adapting Cancer Civil Society Organizations to Accelerate COVID-19 Vaccinations in People Living With Cancer in Low- and Middle-Income Countries-A Commentary.
JCO Glob Oncol
; 7: 1194-1198, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34292779